VPIM
AXSM icon

Vanguard Personalized Indexing Management’s Axsome Therapeutics AXSM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$502K Buy
2,968
+778
+36% +$134K ﹤0.01% 1310
2025
Q4 		$400K Buy
2,190
+89
+4% +$12.4K ﹤0.01% 1367
2025
Q3 		$255K Buy
2,101
+134
+7% +$15.1K ﹤0.01% 1579
2025
Q2 		$205K Buy
+1,967
New +$208K ﹤0.01% 1619

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Personalized Indexing Management's AXSM Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Axsome Therapeutics (AXSM) stake by 36% in Q1 2026, buying an estimated $134K and bringing the position to 2,968 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Vanguard Personalized Indexing Management first reported a position in AXSM in Q2 2025 and has held it in 4 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Vanguard Personalized Indexing Management held 2,968 shares of Axsome Therapeutics worth $502K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 778 Axsome Therapeutics shares in Q1 2026, an estimated $134K.
  • Axsome Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1310 holding.
  • Vanguard Personalized Indexing Management first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.